More Than Ataxia: Hyperkinetic Movement Disorders in Childhood Autosomal Recessive Ataxia Syndromes

Overview

Journal Tremor Other Hyperkinet Mov (N Y)

Publisher Ubiquity Press

Date 2016 Aug 19

PMID 27536460

Citations 14

Authors

Toni S Pearson

Affiliations

Soon will be listed here.

Abstract

Background: The autosomal recessive ataxias are a heterogeneous group of disorders that are characterized by complex neurological features in addition to progressive ataxia. Hyperkinetic movement disorders occur in a significant proportion of patients, and may sometimes be the presenting motor symptom. Presentations with involuntary movements rather than ataxia are diagnostically challenging, and are likely under-recognized.

Methods: A PubMed literature search was performed in October 2015 utilizing pairwise combinations of disease-related terms (autosomal recessive ataxia, ataxia-telangiectasia, ataxia with oculomotor apraxia type 1 (AOA1), ataxia with oculomotor apraxia type 2 (AOA2), Friedreich ataxia, ataxia with vitamin E deficiency), and symptom-related terms (movement disorder, dystonia, chorea, choreoathetosis, myoclonus).

Results: Involuntary movements occur in the majority of patients with ataxia-telangiectasia and AOA1, and less frequently in patients with AOA2, Friedreich ataxia, and ataxia with vitamin E deficiency. Clinical presentations with an isolated hyperkinetic movement disorder in the absence of ataxia include dystonia or dystonia with myoclonus with predominant upper limb and cervical involvement (ataxia-telangiectasia, ataxia with vitamin E deficiency), and generalized chorea (ataxia with oculomotor apraxia type 1, ataxia-telangiectasia).

Discussion: An awareness of atypical presentations facilitates early and accurate diagnosis in these challenging cases. Recognition of involuntary movements is important not only for diagnosis, but also because of the potential for effective targeted symptomatic treatment.

Citing Articles

Exploring the Genetic Landscape of Chorea in Infancy and Early Childhood: Implications for Diagnosis and Treatment.

Spoto G, Ceraolo G, Butera A, Di Rosa G, Nicotera A Curr Issues Mol Biol. 2024; 46(6):5632-5654.

PMID: 38921008 PMC: 11202702. DOI: 10.3390/cimb46060337.

Case report: Compound heterozygous variants detected by next-generation sequencing in a Tunisian child with ataxia-telangiectasia.

Ammous-Boukhris N, Abdelmaksoud-Dammak R, Ben Ayed-Guerfali D, Guidara S, Jallouli O, Kamoun H Front Neurol. 2024; 15:1344018.

PMID: 38882696 PMC: 11178103. DOI: 10.3389/fneur.2024.1344018.

Ataxia Rating Scales: Content Analysis by Linking to the International Classification of Functioning, Disability and Health.

Etoom M, Jahan A, Alghwiri A, Lena F, Modugno N Healthcare (Basel). 2022; 10(12).

PMID: 36553983 PMC: 9778645. DOI: 10.3390/healthcare10122459.

Clinical and genetic study of ataxia with vitamin E deficiency: A case report.

Zhang L, Liu B, Peng D World J Clin Cases. 2022; 10(23):8271-8276.

PMID: 36159513 PMC: 9403667. DOI: 10.12998/wjcc.v10.i23.8271.

Case report: A novel p.Ser168GlufsTer19 mutation in a Chinese family with ataxia with oculomotor apraxia type 1.

Wu X, Dong N, Liu Z, Tang T, Liu M Front Neurol. 2022; 13:873826.

PMID: 36119692 PMC: 9479491. DOI: 10.3389/fneur.2022.873826.

References

SEDGWICK R, BODER E . Progressive ataxia in childhood with particular reference to ataxia-telangiectasia. Neurology. 1960; 10:705-15. DOI: 10.1212/wnl.10.7.705. View

Amiel J, Maziere J, Beucler I, Koenig M, Reutenauer L, Loux N . Familial isolated vitamin E deficiency. Extensive study of a large family with a 5-year therapeutic follow-up. J Inherit Metab Dis. 1995; 18(3):333-40. DOI: 10.1007/BF00710425. View

Koeppen A . The hereditary ataxias. J Neuropathol Exp Neurol. 1998; 57(6):531-43. DOI: 10.1097/00005072-199806000-00001. View

Hoshi E, Tremblay L, Feger J, Carras P, Strick P . The cerebellum communicates with the basal ganglia. Nat Neurosci. 2005; 8(11):1491-3. DOI: 10.1038/nn1544. View

Lohmann E, Kruger S, Hauser A, Hanagasi H, Guven G, Erginel-Unaltuna N . Clinical variability in ataxia-telangiectasia. J Neurol. 2015; 262(7):1724-7. DOI: 10.1007/s00415-015-7762-z. View

Castellotti B, Mariotti C, Rimoldi M, Fancellu R, Plumari M, Caimi S . Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients. Neurogenetics. 2011; 12(3):193-201. DOI: 10.1007/s10048-011-0281-x. View

Nissenkorn A, Levi Y, Vilozni D, Berkun Y, Efrati O, Frydman M . Neurologic presentation in children with ataxia-telangiectasia: is small head circumference a hallmark of the disease?. J Pediatr. 2011; 159(3):466-471.e1. DOI: 10.1016/j.jpeds.2011.02.005. View

Bennett C, La Spada A . Unwinding the role of senataxin in neurodegeneration. Discov Med. 2015; 19(103):127-36. View

Oyama G, Thompson A, Foote K, Limotai N, Abd-El-Barr M, Maling N . Deep brain stimulation for tremor associated with underlying ataxia syndromes: a case series and discussion of issues. Tremor Other Hyperkinet Mov (N Y). 2014; 4:228. PMC: 4101398. DOI: 10.7916/D8542KQ5. View

10.

Ouahchi K, Arita M, Kayden H, Hentati F, Ben Hamida M, Sokol R . Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet. 1995; 9(2):141-5. DOI: 10.1038/ng0295-141. View

11.

Crawford T . Ataxia telangiectasia. Semin Pediatr Neurol. 1999; 5(4):287-94. DOI: 10.1016/s1071-9091(98)80007-7. View

12.

Prudente C, Hess E, Jinnah H . Dystonia as a network disorder: what is the role of the cerebellum?. Neuroscience. 2013; 260:23-35. PMC: 3928686. DOI: 10.1016/j.neuroscience.2013.11.062. View

13.

Angelini L, Erba A, Mariotti C, Gellera C, Ciano C, Nardocci N . Myoclonic dystonia as unique presentation of isolated vitamin E deficiency in a young patient. Mov Disord. 2002; 17(3):612-4. DOI: 10.1002/mds.10026. View

14.

Bostan A, Dum R, Strick P . The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci U S A. 2010; 107(18):8452-6. PMC: 2889518. DOI: 10.1073/pnas.1000496107. View

15.

Le Ber I, Bouslam N, Rivaud-Pechoux S, Guimaraes J, Benomar A, Chamayou C . Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain. 2004; 127(Pt 4):759-67. DOI: 10.1093/brain/awh080. View

16.

Datta N, Hohler A . A new SETX mutation producing AOA2 in two siblings. Int J Neurosci. 2013; 123(9):670-3. DOI: 10.3109/00207454.2013.787616. View

17.

Sekijima Y, Hashimoto T, Onodera O, Date H, Okano T, Naito K . Severe generalized dystonia as a presentation of a patient with aprataxin gene mutation. Mov Disord. 2003; 18(10):1198-200. DOI: 10.1002/mds.10526. View

18.

Aguilar M, KAMOSHITA S, LANDING B, BODER E, SEDGWICK R . Pathological observations in ataxia-telangiectasia. A report of five cases. J Neuropathol Exp Neurol. 1968; 27(4):659-76. View

19.

Criscuolo C, Chessa L, Di Giandomenico S, Mancini P, Sacca F, Grieco G . Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study. Neurology. 2006; 66(8):1207-10. DOI: 10.1212/01.wnl.0000208402.10512.4a. View

20.

Krendel D, Gilchrist J, Johnson A, Bossen E . Isolated deficiency of vitamin E with progressive neurologic deterioration. Neurology. 1987; 37(3):538-40. DOI: 10.1212/wnl.37.3.538. View